( S )‐ML‐SA1 Activates Autophagy via TRPML1‐TFEB Pathway
ChemBioChem · 2024
DOI: 10.1002/cbic.202400506 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Micael R Cunha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center of Medicinal Chemistry, Center for Molecular Biology and Genetic Engineering, Universidade Estadual de Campinas, Av. Dr. André Tosello 550, Ca…. Hauptthemen laut MEDLINE: Autophagy, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Transient Receptor Potential Channels. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: FAPESP, CNPq, CAPES.
Abstract (Originalsprache)
Autophagic flux plays a crucial role in various diseases. Recently, the lysosomal ion channel TRPML1 has emerged as a promising target in lysosomal storage diseases, such as mucolipidosis. The discovery of mucolipin synthetic agonist‐1 (ML‐SA1) has expanded our understanding of TRPML1′s function and its potential therapeutic uses. However, ML‐SA1 is a racemate with limited cellular potency and poor water solubility. In this study, we synthetized rac‐ML‐SA1, separated the enantiomers by chiral liquid chromatography and determined their absolute configuration by vibrational circular dichroism (VCD). In addition, we focused on investigating the impact of each enantiomer of ML‐SA1 on the TRPML1‐TFEB axis. Our findings revealed that (S)‐ML‐SA1 acts as an agonist for TRPML1 at the lysosomal membrane. This activation prompts transcription factor EB (TFEB) to translocate from the cytosol to the nucleus in a dose‐dependent manner within live cells. Consequently, this signaling pathway enhances the expression of coordinated lysosomal expression and regulation (CLEAR) genes and activates autophagic flux. Our study presents evidence for the potential use of (S)‐ML‐SA1 in the development of new therapies for lysosomal storage diseases that target TRPML1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Medicinal Chemistry, Center for Molecular Biology and Genetic Engineering, Universidade Estadual de Campinas, Av. Dr. André Tosello 550, Campinas, 13083-886, Brazil.
- Federal Institute of Education, Science and Technology of São Paulo, Av. Mutinga 951, São Paulo, 05110-000, Brazil.
- Chemistry Institute, Fluminense Federal University, Outeiro de São João Batista s/n, Niterói, 24020-141, Brazil.
- Institute of Science and Technology, Federal University of São Paulo, Talim Street 330, São José dos Campos, 12231-280, Brazil.
- SEPARARE-Chromatography Research Center, Department of Chemistry, Federal University of São Carlos, Rodovia Washington Luiz, s/n Km 235, São Carlos, 13565-095, Brazil.
- Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, University of North Carolina, Pharmacy Lane 301, North Carolina, 27599, United States.
ORCID-Profile: Micael R Cunha, Bruno S Do Amaral, Jéssica E Takarada, Gabriel V Valderrama, Andrea N L Batista, João M Batista, Quezia B Cass, Rafael M Couñago, Katlin B Massirer
Förderung
- FAPESP
- CNPq
- CAPES
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Cunha, M. R., Do Amaral, B. S., Takarada, J. E., Valderrama, G. V., Batista, A. N. L., Batista, J. M., Cass, Q. B., Couñago, R. M., & Massirer, K. B. (2024). ( S )‐ML‐SA1 Activates Autophagy via TRPML1‐TFEB Pathway. ChemBioChem. https://doi.org/10.1002/cbic.202400506
Vancouver
Cunha MR, Do Amaral BS, Takarada JE, Valderrama GV, Batista ANL, Batista JM, et al. ( S )‐ML‐SA1 Activates Autophagy via TRPML1‐TFEB Pathway. ChemBioChem. 2024. doi:10.1002/cbic.202400506
BibTeX
@article{Cunha2024,
author = {Cunha, Micael R and Do Amaral, Bruno S and Takarada, Jéssica E and Valderrama, Gabriel V and Batista, Andrea N L and Batista, João M and Cass, Quezia B and Couñago, Rafael M and Massirer, Katlin B},
title = {( S )‐ML‐SA1 Activates Autophagy via TRPML1‐TFEB Pathway},
journal = {ChemBioChem},
year = {2024},
doi = {10.1002/cbic.202400506}
}
EUVIMED